Quantcast

Sato’s Zentrip Bows Billboard Campaign in Times Square

September 18, 2011

Zentrip, an innovative OTC-drug remedy, uses a medicated thin-film strip for placement on the tongue to stop or relieve motion sickness. Zentrip is being introduced with billboards and ads in major publications.

Torrance, CA (PRWEB) September 18, 2011

Recently launched Zentrip, an innovative OTC remedy for motion sickness using a medicated thin-film strip, is being promoted on giant moving billboards on both the Disney and ABC sites at Times Square, Manhattan.

According to Walter Morimoto, sales manager at Sato Pharmaceutical, “the product will be viewed by over 500,000 people a week in support of Walgreens, our key dealer in Manhattan.” He notes the retailer has a prime flagship outlet on the same block as the billboards.

On a national level, Zentrip is being featured in a travel supplement targeted for placement in the Wall Street Journal and with ads in the travel section of USA Today.

When placed on the tongue for only a few seconds, the tiny fast-dissolving, fast-acting Zentrip strip is designed to prevent all forms of motion sickness – whether in a plane, vehicle, boat or even when watching the latest 3-D movies.

Founded in 1915, Sato Pharmaceutical is an industry trend leader in creating hundreds of healthy lifestyle self-medications, as well as, the company’s popular Yunker Energy drinks.

####

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/9/prweb8804718.htm


Source: prweb



comments powered by Disqus